- Trials with a EudraCT protocol (97)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
97 result(s) found for: Recognition.
Displaying page 1 of 5.
EudraCT Number: 2019-001910-40 | Sponsor Protocol Number: 0305070107 | Start Date*: 2020-06-09 |
Sponsor Name:Radboud University | ||
Full Title: Combining emotion recognition training with oxytocin administration: A psychobiological approach | ||
Medical condition: We examine whether oxytocin administration can improve the effectiveness of emotion recognition training compared to placebo in residential youth with antisocial behavior | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000367-16 | Sponsor Protocol Number: 0305070106 | Start Date*: 2017-03-23 |
Sponsor Name:Radboud University Nijmegen | ||
Full Title: The effect of oxytocin administration on empathy and emotion recognition in healthy and antisocial adolescents | ||
Medical condition: We examine the effect of oxytocin administration on empathy and emotion recognition in healthy adolescents and adolescents with antisocial behavior and history of severe psychological trauma | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000179-34 | Sponsor Protocol Number: P53 | Start Date*: 2013-08-28 |
Sponsor Name:Maastricht University | ||
Full Title: More creative on cocaine? | ||
Medical condition: It is not really a medical condition that is being investigated. The present research proposal has been designed 1) to assess creativity during cocaine intoxication, and 2) to define the potentia... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005739-91 | Sponsor Protocol Number: AGO/2005/006 | Start Date*: 2006-06-21 |
Sponsor Name:University Hospital Ghent | ||
Full Title: Functional Neuroimaging in depression: longitudinal study of PET metabolism in correlation with changes in attentional bias, autobiographical memory, future fluency and facial recognition in depres... | ||
Medical condition: Major depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020223-44 | Sponsor Protocol Number: FinalVersion | Start Date*: 2010-08-03 |
Sponsor Name:Medizinische Universität Wien, Univ.Klinik f.Radiodiagnostik | ||
Full Title: (18)F-FDG PET/CT in patients with idiopathic interstitial pneumonias: correlation of tracer uptake and histological findings, and texture-based recognition of usual interstitial pneumonia | ||
Medical condition: Interstitial lung disease of unknown etiology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2014-005239-15 | Sponsor Protocol Number: MISO | Start Date*: 2016-08-12 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in patients with major depression and healthy controls: what’s the role of NMDA receptors? | ||
Medical condition: depressed patients and healthy control subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004955-64 | Sponsor Protocol Number: E2090-S082-403 | Start Date*: 2017-04-21 |
Sponsor Name:Eisai Korea Inc. | ||
Full Title: A Multicenter Comparative Trial of Zonisamide and Topiramate as Monotherapy in Epilepsy Patients: Safety for cognitive function | ||
Medical condition: Epilepsy | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: (No results available) |
EudraCT Number: 2022-000603-12 | Sponsor Protocol Number: 80655 | Start Date*: 2022-08-05 |
Sponsor Name:Radboud University | ||
Full Title: Oxytocin and reactivity to infant signals in mothers with postpartum depression | ||
Medical condition: We examine the effects of oxytocin on mother-infant interaction among mothers with a postpartum depression | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004323-33 | Sponsor Protocol Number: AC102-201 | Start Date*: 2022-05-06 |
Sponsor Name:AudioCure Pharma GmbH | ||
Full Title: Phase II, Multi-Center, Randomized, Blinded Study Evaluating the Efficacy, Safety and Tolerability of a Single Intratympanic Dose of AC102 Compared to Oral Steroids for the Treatment of Idiopathic ... | ||
Medical condition: Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) ISSNHL is most commonly defined as sensorineural hearing loss of 30dB or greater over at least three contiguous audiometric frequencies occurri... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Trial now transitioned) CZ (Trial now transitioned) BG (Prematurely Ended) AT (Trial now transitioned) NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004959-36 | Sponsor Protocol Number: 446002504 | Start Date*: 2020-09-30 |
Sponsor Name:ZonMw | ||
Full Title: A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment (MCI). | ||
Medical condition: Mild Cognitive Impairment (MCI) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005459-41 | Sponsor Protocol Number: ferucarbotran in Pz. con melanoma | Start Date*: 2007-09-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | |||||||||||||
Full Title: Study of superficial lynmph nodes whit superparamagnetic contrast and RMN in patient affected by melanoma. | |||||||||||||
Medical condition: melanomas of limbs. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001008-13 | Sponsor Protocol Number: SUPERIOR | Start Date*: 2018-07-09 | |||||||||||
Sponsor Name:HELLENIC INSTITUTE FOR THE STUDY OF SEPSIS | |||||||||||||
Full Title: A SUPAR GUIDED DOUBLE BLIND RANDOMIZED CLINICAL TRIAL OF INITIATION OF ANTIBIOTICS FOR PRESUMED INFECTION AT THE EMERGENCY DEPARTMENT: THE SUPERIOR TRIAL | |||||||||||||
Medical condition: Α suPAR guided early antibiotic administration at the Emergency Room for presumed infection and sepsis and evaluation of the impact of this intervention to the patients’ final outcome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005009-30 | Sponsor Protocol Number: | Start Date*: 2016-05-04 | ||||||||||||||||
Sponsor Name:Gloucestershire Hospitals NHS Foundation Trust and | ||||||||||||||||||
Full Title: An open label, randomised controlled feasibility pilot study to evaluate whether nasal fentanyl alone and in combination with buccal midazolam give better symptom control to dying patients when com... | ||||||||||||||||||
Medical condition: Adult hospice in-patients with terminal cancer who are thought to be in the last 1 - 2 weeks of life | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-013403-55 | Sponsor Protocol Number: NL2861002909 | Start Date*: 2009-10-07 |
Sponsor Name:VU university medical center | ||
Full Title: Early recognition and optimal treatment of delirium in patients with advanced cancer. | ||
Medical condition: Delirium in patients with advanced cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005773-27 | Sponsor Protocol Number: APHP190353 | Start Date*: 2021-03-09 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: BARIcitinib Cognitive Emotional and Neural signaTuRE BARICENTRE | |||||||||||||
Medical condition: Patients with rheumatoid arthritis and indication of baricitinib treatment according to a rheumatologist | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002284-22 | Sponsor Protocol Number: SuDHO | Start Date*: 2021-06-25 |
Sponsor Name:Helse-Bergen HF, Haukeland University Hospital | ||
Full Title: Hyperbaric oxygen treatment added to standard care for acute idiopathic sudden sensorineural hearing loss - a multicentre randomized controlled trial | ||
Medical condition: Idiopathic sudden sensorineural hearing loss (ISSNHL) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2009-017798-39 | Sponsor Protocol Number: PROVAX study | Start Date*: 2010-07-08 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: An open label, Phase II study of vaccination with Survivin peptides emulsified in Montanide ISA 51VG after IMP 321 injection in prostate carcinoma patients with biochemical failure (PROVAX study) | |||||||||||||
Medical condition: Prostate cancer, biochemical failure after all potentially curative standard local therapies (radiotherapy, brachytherapy and surgery) or biochemical progression while patients have castrated level... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005741-17 | Sponsor Protocol Number: 76096 | Start Date*: 2021-08-25 |
Sponsor Name:Amsterdam University Medical Centers, location AMC | ||
Full Title: Hyperbaric OXygen therapy for ACute Acoustic Trauma | ||
Medical condition: Acute acoustic trauma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005205-71 | Sponsor Protocol Number: FCE2011 | Start Date*: 2012-04-24 |
Sponsor Name:Leiden University
[...]
1. Leiden University
2. Leiden University Medical Center |
||
Full Title: The effect of fludrocortisone on emotional information processing in healthy volunteers | ||
Medical condition: None. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006126-25 | Sponsor Protocol Number: 06 038 | Start Date*: 2007-06-08 |
Sponsor Name:CNRS: VAN DER REST Michel | ||
Full Title: Emotional and Social deficits in Asperger syndrome | ||
Medical condition: We investigate the Asperger Syndrome, it's a pervasive developmental condition related to autism. It manifests in highly individual ways and can have both positive and negative effects on a person.... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
